Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLC D-99 for Hepatobiliary Carcinomas
NCT00003296Phase 2Unknown
- Sponsor
- Brown University
- Start
- Jan 1998
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in liver carcinoma, extrahepatic bile duct carcinoma (EHBDC), gallbladder carcinoma, sponsored by Brown University. Status: unknown.
02
Drugs
doxorubicin
03
Conditions
liver carcinomaextrahepatic bile duct carcinoma (EHBDC)gallbladder carcinoma
Beyond the preview
Go deeper on NCT00003296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003296.